Q4 2024 Earnings Call Transcript April 1, 2025 Operator: Good afternoon ladies and gentlemen and thank you for standing by.
4don MSN
Q4 2024 Management View CEO Cameron Reynolds highlighted 2024 as a pivotal year for VolitionRx, focusing on generating clinical data to establish the Nu.Q platform's role in oncology and sepsis. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback